Development of Phenothiazine Hybrids with Potential Medicinal Interest: A Review

The molecular hybridization approach has been used to develop compounds with improved efficacy by combining two or more pharmacophores of bioactive scaffolds. In this context, hybridization of various relevant pharmacophores with phenothiazine derivatives has resulted in pertinent compounds with diverse biological activities, interacting with specific or multiple targets. In fact, the development of new drugs or drug candidates based on phenothiazine system has been a promising approach due to the diverse activities associated with this tricyclic system, traditionally present in compounds with antipsychotic, antihistaminic and antimuscarinic effects. Actually, the pharmacological actions of phenothiazine hybrids include promising antibacterial, antifungal, anticancer, anti-inflammatory, antimalarial, analgesic and multi-drug resistance reversal properties. The present review summarizes the progress in the development of phenothiazine hybrids and their biological activity.     

Evaluation of 2-Thioxoimadazolidin-4-one Derivatives as Potent Anti-Cancer Agents through Apoptosis Induction and Antioxidant Activation: In Vitro and In Vivo Approaches

Background: Hepatocellular carcinoma (HCC) is one of the most widespread malignancies and is reported as the fourth most prevalent cause of cancer deaths worldwide. Therefore, we aimed to investigate the probable mechanistic cytotoxic effect of the promising 2-thioxoimidazolidin-4-one derivative on liver cancer cells using in vitro and in vivo approaches. The compounds were tested for the in vitro cytotoxic activity using MTT assay, and the promising compound was tested in colony forming unit assay, flow cytometric analysis, RT-PCR, Western blotting, in vivo using SEC-carcinoma and in silico to highlight the virtual mechanism of action. Both compounds 4 and 2 performed cytotoxic effects against HepG2 cells with IC₅₀ values of 0.017 and 0.18 μM, respectively, compared to Staurosporine and 5-Fu as reference drugs with IC₅₀ values of 5.07 and 5.18 µM, respectively. Compound 4 treatment revealed apoptosis induction by 19.35-fold (11.42% compared to 0.59% in control), arresting the cell cycle at G2/M phase. Moreover, studying gene expression that plays critical roles in cell cycle and apoptosis by RT-PCR demonstrated that compound 4 enhances the expression of the pro-apoptotic genes p53, PUMA, and Caspase 3, 8, and 9, and impedes the anti-apoptotic Bcl-2 gene in the HepG2 cells. It can also inhibit the PI3K/AKT pathway at both gene and protein levels, which was reinforced by the in silico predictions of the molecular docking simulations towards the PI3K/AKT proteins. Finally, in vivo study verified that compound 4 has a promising anti-cancer activity through activating antioxidant levels (CAT, SOD and GSH) and ameliorating hematological, biochemical, and histopathological findings.     

Caseinolytic Proteins (Clp) in the Genus Klebsiella: Special Focus on ClpK

Caseinolytic proteins (Clp), which are present in both prokaryotes and eukaryotes, play a major role in cell protein quality control and survival of bacteria in harsh environmental conditions. Recently, a member of this protein family, ClpK was identified in a pathogenic strain of Klebsiella pneumoniae which was responsible for nosocomial infections. ClpK is linked to the thermal stress survival of this pathogen. The genome wide analysis of Clp proteins in Klebsiella spp. indicates that ClpK is present in only 34% of the investigated strains. This suggests that the uptake of the clpk gene is selective and may only be taken up by a pathogen that needs to survive harsh environmental conditions. In silico analyses and molecular dynamic simulations show that ClpK is mainly α-helical and is highly dynamic. ClpK was successfully expressed and purified to homogeneity using affinity and anion exchange chromatography. Biophysical characterization of ClpK showed that it is predominantly alpha-helical, and this is in agreement with in silico analysis of the protein structure. Furthermore, the purified protein is biologically active and hydrolyses ATP in a concentration- dependent manner.     

一种新型手性功能单体的合成

以手性芳胺为母体,丙烯酰氯为酰化试剂,合成了新型手性功能单体(1)。用1合成了一系列手性分子印迹聚合物。1的结构经1H NMR,IR,MS及元素分析确证。     

血红素蛋白的分子设计新趋向

综述了近年来有关血红素蛋白分子设计所出现的新趋向, 包括氨基酸选择突变与血红素修饰相结合,非天然辅基的引入,非天然氨基酸的引入,辅基与蛋白肽链的共价结合,以及全新血红素蛋白的设计与构建5个方面。这些新发展趋向对研究金属蛋白的结构-功能关系提供了重要的信息,同时也为这些理性设计的新颖金属蛋白分子拓宽了其在生物化学、生物工程和药学上的应用。     

采用新型引发剂乳液聚合法合成高相对分子质量聚乙烯醇

采用新型引发剂偶氮二异(N-胺乙基)丁脒(ABEA)对醋酸乙烯酯的低温乳液聚合进行了研究。通过正交试验得出了高相对分子质量聚醋酸乙烯酯的最佳工艺配方。讨论了引发剂浓度、反应温度和乳化剂浓度对聚合物相对分子质量和转化率的影响。对高相对分子质量聚醋酸乙烯酯醇解工艺进行了探讨,并获得了聚合度为3500~4000的聚乙烯醇。     

分子信标用于p53 mRNA的体外定量检测

根据p53基因的序列设计并合成了能特异性检测p53 mRNA的分子信标(MB), 发展了一种快速定量测定细胞内总RNA提取物中p53 mRNA的方法. 采用鼻咽癌(CNE2)细胞系和经RNA干扰技术降低p53基因表达的CNE2-p53RNAi细胞系, 抽提总RNA并用MB检测, 验证了MB的检测对象是p53 mRNA. 将该方法应用于多种肿瘤细胞内p53基因表达水平的分析, 表达变化趋势与经典的mRNA分析方法RT-PCR检测结果相符. 在此基础上, 用MB对5-氟尿嘧啶(5-Fu)处理的肺腺癌细胞(A549)进行了p53 mRNA的体外定量检测, 结果表明采用MB能够快速地获知该药物对细胞内p53 mRNA表达影响的信息.     

锂-,钠-,钾水化蒙脱石层间结构的分子动力学模拟

运用分子动力学(molecular dynamics, MD)方法分别研究了含有32, 64和96个水分子的Li-, Na-, K-蒙脱石层间阳离子与水分子的位置和结构. 计算结果表明蒙脱石层间阳离子位置与四面体和八面体电荷位置及离子的大小有关. 一层水合物中可以观察到三种阳离子都能和四面体电荷与八面体电荷位置分别形成内、外配位作用. 二层水合物中, 仍然可以观察到Li^＋和Na^＋与电荷位置的配位作用, 但是已经开始向层中其他方向扩散, 而K^＋仍然在粘土的表面附近. 三层水合物中, Li^＋, Na^＋开始从电荷位置和表面分离, K^＋也开始向层间其他方向扩散. 水分子在所有三种水合物中都分散于层间各个方向. 径向分布函数的分析结果表明层间三种阳离子组织水分子的能力不同, 水化作用随着阳离子半径的增大而减弱; 此外层中水分子的聚合程度随着水分子的增加而加强, 水分子的结构也不同于模拟的液体水分子的结构; 说明蒙脱石层间阳离子的溶剂化作用对水分子的组织起着重要的作用.     

多金属氧酸盐/介孔分子筛杂化材料的制备与表征

采用嵌段共聚物模板P123和缺位Keggin结构的多金属氧酸盐K₈SiW₁₁O₃₉•12H₂O, 由溶胶-凝胶法合成了具有类六方结构的SiW₁₁/SBA-15杂化介孔分子筛材料, 并通过X射线衍射(XRD)、傅立叶变换红外光谱(FT-IR)、紫外漫反射光谱(UV/DRS)、电感耦合等离子原子发射光谱(ICP-AES)、低温N₂吸附、透射电子显微镜(TEM)等手段对其进行了表征. 结果表明, 杂化材料中不仅规整均一的类六方介孔结构得以保持, 而且多金属氧酸盐的Keggin单元保留完整(含量达25%左右), 并共价键联于介孔材料的孔道内部. 稳定性实验表明, 杂化材料中多金属氧酸盐在水中的流失率远低于一般浸渍法制备的样品.     

铁氰化钾-鲁米诺体系后化学发光反应及其分析应用研究-分子印迹-后化学发光法测定双嘧达莫

研究了双嘧达莫在铁氰化钾-鲁米诺化学发光反应体系中的后化学发光反应, 并在研究其反应的动力学性质、化学发光光谱、荧光光谱以及一些相关问题的基础上, 探讨了反应机理; 合成了双嘧达莫的分子印迹聚合物, 以此聚合物为分子识别物质, 利用铁氰化钾-鲁米诺-双嘧达莫后化学发光体系, 建立了测定双嘧达莫的高选择性分子印迹-后化学发光分析方法. 所建方法的线性范围为1.0×10-8-1.0×10-6 g/mL(r=0.999 2), 检出限为3×10-9 g/mL, 相对标准偏差为2.7%(1.0×10-7 g/mL双嘧达莫, n=11).